Follow
Dr. ASHOK P
Dr. ASHOK P
Unknown affiliation
Verified email at pilani.bits-pilani.ac.in
Title
Cited by
Cited by
Year
Synthesis and study of anti-HIV-1 RT activity of 5-benzoyl-4-methyl-1, 3, 4, 5-tetrahydro-2H-1, 5-benzodiazepin-2-one derivatives
S Chander, CR Tang, HM Al-Maqtari, J Jamalis, A Penta, TB Hadda, ...
Bioorganic chemistry 72, 74-79, 2017
752017
Manzamine alkaloids: isolation, cytotoxicity, antimalarial activity and SAR studies
P Ashok, S Ganguly, S Murugesan
Drug Discovery Today 19 (11), 1781-1791, 2014
732014
Review on in-vitro anti-malarial activity of natural β-carboline alkaloids
P Ashok, S Ganguly, S Murugesan
Mini Reviews in Medicinal Chemistry 13 (12), 1778-1791, 2013
592013
Manzamine alkaloids as antileishmanial agents: A review
P Ashok, H Lathiya, S Murugesan
European Journal of medicinal chemistry 97, 928-936, 2015
572015
Design, synthesis of new β-carboline derivatives and their selective anti-HIV-2 activity
P Ashok, S Chander, J Balzarini, C Pannecouque, S Murugesan
Bioorganic & medicinal chemistry letters 25 (6), 1232-1235, 2015
542015
Design, synthesis and in-vitro evaluation of novel tetrahydroquinoline carbamates as HIV-1 RT inhibitor and their antifungal activity
S Chander, P Ashok, YT Zheng, P Wang, KS Raja, A Taneja, ...
Bioorganic chemistry 64, 66-73, 2016
422016
Biological evaluation and structure activity relationship of 9-methyl-1-phenyl-9H-pyrido [3, 4-b] indole derivatives as anti-leishmanial agents
P Ashok, S Chander, TK Smith, RP Singh, PN Jha, M Sankaranarayanan
Bioorganic Chemistry 84, 98-105, 2019
382019
Rational design, synthesis, anti-HIV-1 RT and antimicrobial activity of novel 3-(6-methoxy-3, 4-dihydroquinolin-1 (2H)-yl)-1-(piperazin-1-yl) propan-1-one derivatives
S Chander, P Wang, P Ashok, LM Yang, YT Zheng, S Murugesan
Bioorganic Chemistry 67, 75-83, 2016
372016
Synthesis and anti-leishmanial evaluation of 1-phenyl-2, 3, 4, 9-tetrahydro-1H-β-carboline derivatives against Leishmania infantum
P Ashok, S Chander, A Tejeria, L Garcia-Calvo, R Balana-Fouce, ...
European Journal of Medicinal Chemistry 123, 814-821, 2016
362016
Design, Synthesis, and Biological Evaluation of 1‐(thiophen‐2‐yl)‐9H‐pyrido[3,4‐b]indole Derivatives as Anti‐HIV‐1 Agents
P Ashok, CL Lu, S Chander, YT Zheng, S Murugesan
Chemical Biology & Drug Design 85 (6), 722-728, 2015
352015
Design, synthesis and biological evaluation of piperazinyl-β-carbolinederivatives as anti-leishmanial agents
P Ashok, S Chander, TK Smith, M Sankaranarayanan
European Journal of medicinal chemistry 150, 559-566, 2018
292018
Synthesis and in-vitro anti-leishmanial activity of (4-arylpiperazin-1-yl)(1-(thiophen-2-yl)-9H-pyrido [3, 4-b] indol-3-yl) methanone derivatives
P Ashok, S Chander, LMC Chow, ILK Wong, RP Singh, PN Jha, ...
Bioorganic Chemistry 70, 100-106, 2017
262017
Design, synthesis and evaluation of diarylpiperazine derivatives as potent anti-tubercular agents
A Penta, S Franzblau, B Wan, S Murugesan
European Journal of Medicinal Chemistry 105, 238-244, 2015
262015
De-novo design, synthesis and evaluation of novel 6, 7-dimethoxy-1, 2, 3, 4-tetrahydroisoquinoline derivatives as HIV-1 reverse transcriptase inhibitors
S Chander, P Ashok, A Singh, S Murugesan
Chemistry Central Journal 9, 1-13, 2015
252015
Molecular docking and molecular dynamics simulation based approach to explore the dual inhibitor against HIV-1 reverse transcriptase and Integrase
S Chander, RK Pandey, A Penta, BS Choudhary, M Sharma, R Malik, ...
Combinatorial chemistry & high throughput screening 20 (8), 734-746, 2017
232017
Hit optimization studies of 3-hydroxy-indolin-2-one analogs as potential anti-HIV-1 agents
S Chander, CR Tang, A Penta, P Wang, DP Bhagwat, N Vanthuyne, ...
Bioorganic Chemistry 79, 212-222, 2018
222018
Design, synthesis and anti-HIV-1 RT evaluation of 2-(benzyl (4-chlorophenyl) amino)-1-(piperazin-1-yl) ethanone derivatives
S Chander, P Wang, P Ashok, LM Yang, YT Zheng, M Sankaranarayanan
Bioorganic & Medicinal Chemistry Letters 27 (1), 61-65, 2017
182017
Design and synthesis of tetrahydrophthalimide derivatives as inhibitors of HIV-1 reverse transcriptase
A Penta, S Ganguly, S Murugesan
Organic and medicinal chemistry letters 3, 1-8, 2013
152013
De novo design and in-silico studies of novel 1-phenyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid derivatives as HIV-1 reverse transcriptase …
A Penta, S Chander, S Ganguly, S Murugesan
Medicinal Chemistry Research 23, 3662-3670, 2014
142014
In-silico design and study of novel piperazinyl β-carbolines as inhibitor of HIV-1 reverse transcriptase
P Ashok, H Sharma, H Lathiya, S Chander, S Murugesan
Medicinal Chemistry Research 24, 513-522, 2015
132015
The system can't perform the operation now. Try again later.
Articles 1–20